415 related articles for article (PubMed ID: 6355362)
1. Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function.
Hercend T; Meuer S; Brennan A; Edson MA; Acuto O; Reinherz EL; Schlossman SF; Ritz J
J Exp Med; 1983 Nov; 158(5):1547-60. PubMed ID: 6355362
[TBL] [Abstract][Full Text] [Related]
2. Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure.
Hercend T; Meuer S; Brennan A; Edson MA; Acuto O; Reinherz EL; Schlossman SF; Ritz J
Cell Immunol; 1984 Jul; 86(2):381-92. PubMed ID: 6610481
[TBL] [Abstract][Full Text] [Related]
3. Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell lines.
Hercend T; Schmidt R; Brennan A; Edson MA; Reinherz EL; Schlossman SF; Ritz J
Eur J Immunol; 1984 Sep; 14(9):844-52. PubMed ID: 6479209
[TBL] [Abstract][Full Text] [Related]
4. Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity.
Schmidt RE; Bartley GT; Lee SS; Daley JF; Royer HD; Levine H; Reinherz EL; Schlossman SF; Ritz J
J Exp Med; 1986 Apr; 163(4):812-25. PubMed ID: 3485172
[TBL] [Abstract][Full Text] [Related]
5. Functional surface structures on human natural killer cells.
Schmidt RE; Hercend T; Schlossman SF; Ritz J
Klin Wochenschr; 1985 Dec; 63(23):1189-200. PubMed ID: 2418257
[TBL] [Abstract][Full Text] [Related]
6. A target structure for a series of human cloned natural killer cell lines is recognized by both anti-TNKtar and 4F2 monoclonal antibodies.
Moingeon P; Nowill A; Courtois G; Azzarone B; Motte P; Ythier A; Bohuon C; Hercend T
J Immunol; 1985 May; 134(5):2930-4. PubMed ID: 3980986
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
Schmidt RE; Bartley G; Levine H; Schlossman SF; Ritz J
J Immunol; 1985 Aug; 135(2):1020-5. PubMed ID: 3924996
[TBL] [Abstract][Full Text] [Related]
8. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines.
Spits H; Keizer G; Borst J; Terhorst C; Hekman A; de Vries JE
Hybridoma; 1983; 2(4):423-37. PubMed ID: 6332061
[TBL] [Abstract][Full Text] [Related]
10. Generation of monoclonal antibodies blocking cytotoxic reactions by human NK clones: further characterization of a 40/80-kDa target cell receptor.
Ythier A; Moingeon P; Fabbi M; Delmon L; Nowill A; Troelen F; Bohuon C; Hercend T
Cell Immunol; 1986 Apr; 99(1):150-9. PubMed ID: 2428527
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
12. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.
Meuer SC; Schlossman SF; Reinherz EL
Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4395-9. PubMed ID: 6981813
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
[TBL] [Abstract][Full Text] [Related]
14. Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.
Moretta A; Pantaleo G; Mingari MC; Moretta L; Cerottini JC
J Exp Med; 1984 Mar; 159(3):921-34. PubMed ID: 6421984
[TBL] [Abstract][Full Text] [Related]
15. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
16. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
[TBL] [Abstract][Full Text] [Related]
17. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
[TBL] [Abstract][Full Text] [Related]
18. The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigens.
Spits H; Yssel H; Voordouw A; de Vries JE
J Immunol; 1985 Apr; 134(4):2294-8. PubMed ID: 2579137
[TBL] [Abstract][Full Text] [Related]
19. Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones.
Bensussan A; Tourvieille B; Chen LK; Dausset J; Sasportes M
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6642-6. PubMed ID: 3876559
[TBL] [Abstract][Full Text] [Related]
20. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
